FROST PHILLIP MD ET AL bought COCP

November 26, 2025 · Form 4 insider transaction

FROST PHILLIP MD ET AL bought 2,500 shares of Cocrystal Pharma, Inc. at $0.99 per share, a transaction worth $2.5K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
2,500
Price
$0.99
Total value
$2.5K
RoleOfficer, Director, 10% owner
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateNovember 26, 2025
Filing dateNovember 28, 2025
Shares owned after1,703,551
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

These shares are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole stockholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is the sole stockholder of Frost-Nevada Corporation. The Reporting Person disclaims beneficial ownership of the securities held by Frost Gamma Investments Trust except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

View the original Form 4 on SEC EDGAR